Helen Sheldon

Helen Sheldon

UNVERIFIED PROFILE

Are you Helen Sheldon?   Register this Author

Register author
Helen Sheldon

Helen Sheldon

Publications by authors named "Helen Sheldon"

Are you Helen Sheldon?   Register this Author

16Publications

298Reads

38Profile Views

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.

Proc Natl Acad Sci U S A 2019 Jun 31;116(25):12452-12461. Epub 2019 May 31.

Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1818521116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589752PMC
June 2019

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.

Oncotarget 2017 Jun;8(25):40115-40131

Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522274PMC
June 2017

The role of the dementia specialist nurse in acute care: a scoping review.

J Clin Nurs 2015 May 3;24(9-10):1394-405. Epub 2014 Dec 3.

Faculty of Health Sciences, University of Southampton, Southampton and National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (Wessex), UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocn.12717DOI Listing
May 2015

A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.

Angiogenesis 2015 Apr 4;18(2):209-17. Epub 2015 Jan 4.

Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10456-014-9457-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363482PMC
April 2015

Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer.

Oncotarget 2015 Mar;6(8):5678-94

Department of Oncology, Molecular Oncology Laboratories, The Weatherall Institute of Molecular Medicine, University of Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467394PMC
http://dx.doi.org/10.18632/oncotarget.3296DOI Listing
March 2015

microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.

Cancer Res 2011 Sep 7;71(17):5635-45. Epub 2011 Jul 7.

Oncology Department, Weatherall Institute of Molecular Medicine, University of Oxford and Genomics Research, Wellcome Trust Centre for Human Genetics, Oxford, UK.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-11-0489DOI Listing
September 2011

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.

Cancer Res 2011 Sep 29;71(18):6073-83. Epub 2011 Jul 29.

Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-1704DOI Listing
September 2011

New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes.

Blood 2010 Sep 17;116(13):2385-94. Epub 2010 Jun 17.

Cancer Research UK Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-08-239228DOI Listing
September 2010

Functionally defining the endothelial transcriptome, from Robo4 to ECSCR.

Biochem Soc Trans 2009 Dec;37(Pt 6):1214-7

Institute for Biomedical Research, Birmingham University Medical School, Vincent Drive, Birmingham B15 2TT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BST0371214DOI Listing
December 2009

Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.

Clin Cancer Res 2009 Nov 3;15(22):7069-76. Epub 2009 Nov 3.

Departments of Pathology, and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0688DOI Listing
November 2009

Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms.

Microvasc Res 2009 May 27;77(3):314-26. Epub 2009 Jan 27.

Cancer Research UK Department of Medical Oncology, Weatherall Institute of Molecular Medicine, Oxford OX3 9DS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mvr.2009.01.003DOI Listing
May 2009

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.

Clin Cancer Res 2008 Mar;14(5):1340-8

Genomics Group, Wellcome Trust Centre for Human Genetics, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/14/5/1340.full
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-07-1755DOI Listing
March 2008